|D055370||Lung Injury NIH||0.18|
|D014947||Wounds and Injuries NIH||0.18|
|D055371||Acute Lung Injury NIH||0.08|
There is one clinical trial.
Preparing to deal with Covid-19 outbreak in Rajasthan, India, health care workers were given Ayurvedic Kadha (combination of ayurvedic herbal extracts) starting from the end of February 2020. Then, majority of these health care workers were put on front line managing screening, monitoring, quarantine and treating Covid 19 patients. This real-life study aimed to determine the experience of health care workers who had Ayurveda kadha before starting as front-line workers.
Description: Self-reported health issuesMeasure: Physical Health Time: From baseline to 30-days
Description: Self-reported psychological issuesMeasure: Psychological Health Time: From baseline to 30-days
Description: Self-reported coping with high demanding work in Covid-19 dutiesMeasure: Coping with distress Time: From baseline to 30-days
Description: Self reported self-help measures usedMeasure: Self-Help Time: From baseline to 30-days
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports